S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   169.14 (-2.06%)
MSFT   416.49 (+0.69%)
META   502.99 (+0.55%)
GOOGL   154.77 (-0.06%)
AMZN   184.12 (+0.27%)
TSLA   156.88 (-2.85%)
NVDA   869.70 (+1.13%)
AMD   163.08 (+1.72%)
NIO   3.82 (-1.80%)
BABA   69.63 (-1.40%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   120.89 (-0.40%)
GE   155.26 (+1.01%)
CGC   7.00 (+0.29%)
DIS   114.30 (+1.20%)
AMC   2.70 (+9.31%)
PFE   25.83 (-0.31%)
PYPL   64.05 (+0.85%)
XOM   118.77 (-0.76%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   169.14 (-2.06%)
MSFT   416.49 (+0.69%)
META   502.99 (+0.55%)
GOOGL   154.77 (-0.06%)
AMZN   184.12 (+0.27%)
TSLA   156.88 (-2.85%)
NVDA   869.70 (+1.13%)
AMD   163.08 (+1.72%)
NIO   3.82 (-1.80%)
BABA   69.63 (-1.40%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   120.89 (-0.40%)
GE   155.26 (+1.01%)
CGC   7.00 (+0.29%)
DIS   114.30 (+1.20%)
AMC   2.70 (+9.31%)
PFE   25.83 (-0.31%)
PYPL   64.05 (+0.85%)
XOM   118.77 (-0.76%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   169.14 (-2.06%)
MSFT   416.49 (+0.69%)
META   502.99 (+0.55%)
GOOGL   154.77 (-0.06%)
AMZN   184.12 (+0.27%)
TSLA   156.88 (-2.85%)
NVDA   869.70 (+1.13%)
AMD   163.08 (+1.72%)
NIO   3.82 (-1.80%)
BABA   69.63 (-1.40%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   120.89 (-0.40%)
GE   155.26 (+1.01%)
CGC   7.00 (+0.29%)
DIS   114.30 (+1.20%)
AMC   2.70 (+9.31%)
PFE   25.83 (-0.31%)
PYPL   64.05 (+0.85%)
XOM   118.77 (-0.76%)
S&P 500   5,062.98 (+0.02%)
DOW   37,900.13 (+0.44%)
QQQ   431.09 (+0.01%)
AAPL   169.14 (-2.06%)
MSFT   416.49 (+0.69%)
META   502.99 (+0.55%)
GOOGL   154.77 (-0.06%)
AMZN   184.12 (+0.27%)
TSLA   156.88 (-2.85%)
NVDA   869.70 (+1.13%)
AMD   163.08 (+1.72%)
NIO   3.82 (-1.80%)
BABA   69.63 (-1.40%)
T   16.08 (-0.99%)
F   12.13 (-0.82%)
MU   120.89 (-0.40%)
GE   155.26 (+1.01%)
CGC   7.00 (+0.29%)
DIS   114.30 (+1.20%)
AMC   2.70 (+9.31%)
PFE   25.83 (-0.31%)
PYPL   64.05 (+0.85%)
XOM   118.77 (-0.76%)
NASDAQ:RIBT

RiceBran Technologies (RIBT) Stock Price, News & Analysis

$0.20
+0.02 (+8.11%)
(As of 11:58 AM ET)
Today's Range
$0.14
$0.20
50-Day Range
$0.09
$0.21
52-Week Range
$0.07
$1.17
Volume
10,563 shs
Average Volume
21,332 shs
Market Capitalization
$2 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
RIBT stock logo

About RiceBran Technologies Stock (NASDAQ:RIBT)

RiceBran Technologies, together with its subsidiaries, operates as a specialty ingredient company in the United States and internationally. It focuses on development, production, and marketing of products derived from rice and other small and ancient grains for the nutraceutical, healthy food, companion animal, and equine feed categories. The company converts raw rice bran into stabilized rice bran (SRB) and high value SRB derivative products, including RiBalance, a complete rice bran nutritional package derived from further processing of SRB; RiSolubles, a nutritious, carbohydrate, and lipid rich fraction of RiBalance; RiFiber, a protein and fiber rich insoluble derivative of RiBalance; and ProRyza products, which includes derivatives composed of protein and protein/fiber blends. It serves food and animal nutrition manufacturers, wholesalers, and retailers. The company was formerly known as NutraCea and changed its name to RiceBran Technologies in October 2012. RiceBran Technologies was founded in 2000 and is headquartered in Tomball, Texas.

RIBT Stock Price History

RIBT Stock News Headlines

Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
RiceBran Technologies Sells Golden Ridge Milling Facility
Can't believe it's happening again
One of the single most unique and powerful events in the markets is coming in the next two months. It’s scheduled for April 22, 2024. But investors are moving now to get ahead of what’s coming… driving up prices of one asset dramatically. And you should do the same.
RiceBran Technologies Reports Third Quarter 2023 Results
RiceBran Technologies RIBT
RiceBran Technologies Sells SRB Business
Q1 2023 RiceBran Technologies Earnings Call
See More Headlines
Receive RIBT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for RiceBran Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/27/2021
Today
4/16/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Industry
Grain mill products
Sub-Industry
N/A
Current Symbol
NASDAQ:RIBT
Employees
94
Year Founded
N/A

Profitability

Net Income
$-17,560,000.00
Pretax Margin
-37.70%

Debt

Sales & Book Value

Annual Sales
$22.65 million
Book Value
($0.32) per share

Miscellaneous

Free Float
9,401,000
Market Cap
$1.85 million
Optionable
Not Optionable
Beta
0.47
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

  • Mr. Eric Tompkins (Age 63)
    Executive Chairman
  • Mr. William J. Keneally (Age 61)
    Interim CFO & Secretary
  • Dr. Rani Madhavapeddi Patel
    Chief Science Officer
  • Ms. Sherry Rhoads
    Vice President of Compliance, Regulatory & External Affairs
  • Dr. Joseph Gutman M.D.
    Strategic Consultant & Member of Medical Advisory Board

RIBT Stock Analysis - Frequently Asked Questions

How have RIBT shares performed in 2024?

RiceBran Technologies' stock was trading at $0.2325 at the beginning of 2024. Since then, RIBT shares have decreased by 14.0% and is now trading at $0.20.
View the best growth stocks for 2024 here
.

How were RiceBran Technologies' earnings last quarter?

RiceBran Technologies (NASDAQ:RIBT) announced its quarterly earnings data on Wednesday, October, 27th. The company reported ($0.50) EPS for the quarter, missing the consensus estimate of ($0.30) by $0.20. The firm had revenue of $6.91 million for the quarter. RiceBran Technologies had a negative trailing twelve-month return on equity of 427.39% and a negative net margin of 77.53%.

When did RiceBran Technologies' stock split?

RiceBran Technologies shares reverse split on Friday, August 26th 2022. The 1-10 reverse split was announced on Friday, August 26th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, August 26th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of RiceBran Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RiceBran Technologies investors own include OPKO Health (OPK), vTv Therapeutics (VTVT), Pareteum (TEUM), Purple Biotech (KTOV), Onconova Therapeutics (ONTX), Palatin Technologies (PTN), Trevena (TRVN), VBI Vaccines (VBIV), Vistagen Therapeutics (VTGN) and Alimera Sciences (ALIM).

How do I buy shares of RiceBran Technologies?

Shares of RIBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:RIBT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners